Nursing Notes

November 3, 2009

Virulent Strain of MRSA Resists Treatment

MIAMI - OCTOBER 17:  Dr. Gio Baracco, director...
Image by Getty Images via Daylife

 

As a nurse in a psychiatric hospital, I am very alarmed by this article.  It seems that MRSA has become commonplace with the population I serve and my patients are not known for being compliant with therapy.  As a nurse, working with these patients, I frequently wonder if I will become infected despite the use of universal precautions.

This article is important to all nurses and future nurses.  We need to be informed of the potential risks we face and we need to understand the possible outcomes if we are to do our jobs and not become infected.

Please read the following article and then visit the website at the end to obtain more information.

 


Type that causes bloodstream infections can be quickly fatal, study finds

SUNDAY, Nov. 1 (HealthDay News) — New research holds bad news for health officials worried about a potentially lethal infection called MRSA that haunts hospitals: A strain that infects the bloodstream is five times more deadly than other strains.

To make matters worse, the USA600 strain appears to be at least partially immune to an antibiotic that’s used to treat the condition, the researchers have found.

A full half of patients infected with the strain died within a month, according to a study scheduled to be presented at the annual meeting of the Infectious Diseases Society of America, held Oct. 29 to Nov. 1 in Philadelphia. That’s nearly five times the death rate of other people infected with MRSA, and 10 to 30 percent of those who acquire

MRSA infections in the bloodstream die within a month, the study found.MRSA, or methicillin-resistant Staphylococcus aureus, causes infections in the skin and bloodstream. It can also infect surgical wounds and cause pneumonia. In most cases, it sickens people in the hospital, but cases are becoming more common outside the health-care community, according to information in a news release from the Henry Ford Health System.

Researchers think it’s possible that the USA600 strain is unique. But they don’t know if other factors — such as the age of patients — could be at play.

Those who developed the USA600 strain tended to be older than those who acquired other MRSA strains, averaging 64 compared with 52 years old, the study noted.

“While many MRSA strains are associated with poor outcomes, the USA600 strain has shown to be more lethal and cause high mortality rates,” Dr. Carol Moore, the study’s lead author and a research investigator at the Henry Ford Hospital’s division of infectious diseases, said in the news release.

“In light of the potential for the spread of this virulent and resistant strain and its associated mortality,” she said, “it is essential that more effort be directed to better understanding this strain to develop measures for managing it.

“MRSA is challenging to treat because strains can be immune to many medications. The USA600 strain appears to be more immune than other strains to the drug vancomycin, which often still has the power to vanquish MRSA.

More information

The U.S. Centers for Disease Control and Prevention has more about MRSA.

 

HealthDay

Reblog this post [with Zemanta]
Advertisements

Leave a Comment »

No comments yet.

RSS feed for comments on this post. TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: